l-l:i,,,'l:18,,'lEIE U!:
KI.TTRIC}I
8E
ll-4-537-:t33
I,iITTRICH I:[EF-DALLAS
CORFORATI.ON
Effectlve DaEo: 5-15-89
MATIIRIAL SA]IBff DATA SIIEET
NO BUGS }T'IADY SIIBLF PATER
SECTION
I:
PRODUCT IDEHTIFI.CATION
PR0DUCTS TMDE NAME:
PR0DUCT CODE NU}IBER:
N0 BIIGS M'LADY SIIELF PAPEIT
CIIEMICAL
CIIEMICAL
Carbantste T-nsectici"de
FAl"tIl,Y:
N1l,l'18:
SYNONYI'IS:
T.S.C.A. STATUS:
(IZ Propoxur)
12" and lB" widths
2-(l-MeEliylethoxy)phenol methylcrrrbamate
Aproca:;l:r, SENDMN, Unden, lropoxur, Sut"j-d.
1{eglsrerec[ untler FLFM, therefore, excLuded
fron
TSCI\
regulation'
ilSHA ITAZARD COI&IUNIC/\TI0N STATUS: This pfodrrct is hazardous under the criteria of
rhe Felleral 0SI{A Hazartl Communication Standard 29 CFR 1910.I2.00.
SARA
TITLII III DATrL: Section ll1 &
312- llPA llaz.ard
Categories:
X Imnediate Health Hazar:d
X Delayed Health llazard
_
NFPA 704M
Ratiflgs:
Suaaen Pressure Release l'lazar<i
0=Insignlficant
3-High
l-Slig,hi
Fire Hazatd
-Reactive Hazard
2=Moderare
4=Extreme
0 Ouher 0 FlanmablJ.ity 0 Reactivity
I llealth
0
STRUCTLIRE:
tt
21
cH,-HH-C-O-(-\
-}/
CH,-CH-O
I
CHt
IIC0I.!P0NENTS:
BAYGON cAS/l
ri4-26*l
IIAZARDOUS INGREDIENTS:
U
OSUA
17,
0'.5
I'EL
rng/m3
ACGIU-TLV
0.5
mg/m3
L-'l':i,'r:11,,''
![-i].
_1 [!: Lli_r :],4-E:rl-!.J:rt
MSDS; NO BUGS M'LADY St-lELI'
Page
F:
ITTEIIH {ltlRP-DALLA5
PAGE
E?
PAPER
2
PEYSICAL DATA:
APPEAR-CINCE. . . . . . . . ,
,,.
Tan
MCI,ECULAR WEIGIIT. . . . . .
:
MEI,T POINT/FREE?.E POTNT
TTOILTNG POINT........ . ;
VAPOR PRESSURE. ^ ^.....;
VAPOR DENSITY (Alr=l). ;
SPECIFIC GRAVITY..... . :
EULK
Sr:r.l.id GranuLes
:
.....,.,..:
...,.:
c0L0R.
0D0R.
DENSITY..........
:
SOLUBILITY IN WATER... i
Z VOLATILE BY VOLUMD..;
:
S1.1ght Phenol
209.2 (For Baygon)
Noc Applicable
Not Apptlqable
9.7 n I0-b
mm Hg
Et 20"C (for
0. 1BZ
(for
Baygorr)
Not Apltllcable
FIRE & EPLOSION
FLASIT POTNTS
FLAMMA,BLE
Lel...
Uel..
:
Not Appllcable
,. +..... !
....... .;
I"IEDIA. ., :
Not Applieable
Not Appl{cabl-e
I.Iater Spray
'I'("C).
..
LIMITS:
EXTINCUISHING
Baygon)
Not AppllcabIe
Noc Applicable
,lpproi, 20 lb . / fi.3
DATA
out of smoke,
tlse
positlon.
caol expoaed contal-ners wlth watex $pfay, Fight flre from uPwind
pel.f-contained breathing eqtrlpmenE. Contain runoff to prevent entry l-nto gewets or
'*rater\^rays. Equipment or fiaterlrls lnvolved in pestlcl-de ftres may become contaminated.
SFF.CIAL FIRE FIGETING PR0CEDTIRES/IINUSUAI FIRE OR ErPLOSTOI{ HAT.ARDS: Keep
V.
FRIIIARY ROUTE(S) OF
EITMAN
ACUTE,
trEAI,TE EFFECTS
DA,TA
Derma-l coRtact and inhelat{.on of che product are thE
prlmary r(:)utos of errtry. This matertal can he absorbed thtough
the skln.
ENIRY:
EffECTS AND SII,TFTOI,$ OF OVER HKPOSI]REI
Inhalatlon, dermal- abeorptlon or in.gestion of th.is m.aterial
may resul.t 1-n systernic j.n,toxJ.catlon due to tnhibtttorr of the eflzlme
chol{nestersse, The sequence of development of systenic effects varies with
th.e rortte of ontr'y, and the onset of syttrptoms may be delayed up to 12 hours.
Fl-ret symptoms of pol-sonlng rnay be nausea, increased sal-J.vation, lacrlmatlon,
blurred vision and cdnstrl-cted pupll-s. Other Bymptoms of syeteml-c poleonlng
inclrrde vomitlng, diarrhea, sbdominal cramplng, d.LzzLness and sweatlflg, After
i,nhalation, respLratory $ymptom'E lllce tlghtnee+ of chentl vheezing and
the polsonlng Is severe, then
Iaryngeal- Epasils, ftay be pronounced st flrst.I.f
symptoms of convulsions, lr:w lilood pressure, cardiac lffeguj.aritles, Ioss of
reflexes and coma may occur, Ifl eEtreile cege, death fiay occur due to a
combination of factor:$ sltch as ]resFiratory arrest, paralyste of resplratory
rltugcles or intense lltonchoconstrictions. Cornplete synptonatic recovery froill
suhlethal polsonln.g usr.rally occurs wit,hln 24-48 hours once the source of
exDosnre ls comul-etelv removed.
u::
'r:-ls
j:EL l-1
rli:
EE
lI4-837-::j::r
MSDS: NO BI]GS MII,ADY SHELF
Page 3
Anlmal" scudles have shovm
FiITTEICH r:llEP-0,{LLA5
FAGE
N3
PAPER
that this product is a mild eye lrrltant.
cmONIc.,,,.,..,;
Illgh dosee of propoxur lflduced blsdder caflcers when fed to tats
in one study. Cancer vras not induced in several ot.her feedlng st.udl-es on rats
other manrmals. The lmpllcatlons of these stud{es for humans sre not knovrn,
and
tests conducted r.ri.th Propoxur technical, this product Le not expected
to be seneltl-zlng f,o the ekln.
Based on
HIDICAL CONDITIONS AGGRAVATFD BY llXPOSlIRfi; No epeclflc medlcaL eondl-clons are known
which may he aggravate<l by exp6strxa to the actLve lngredlent ln this product;
hotoever, any disease, medicatlon or prior exposure which reduces normal
cholinesterase actl.vity nay lncrease strseeptlbllity to the toxlc eff@cts of
the active lngredient.
CARCII{0GENICITYT
NTP - Not Lleced
IARC - Not Listed
0SI{A - Not Listed
VI.
EYE
TIMERGF-NCT
& TJIRST AIIT
PROCEI}IIRFS;
CONTACT,,.,....,.. .: Hold eyellds opeu and flush with copious amounts of water
for t5 illiluf,es. Cal-l a physlc{sn lf {rrl-tati-on develops or persist.$ after flunhlng.
S:{IN
CONTACT...,......,: Remove contamlnated clothirrg, Wa$h skin wtth soap and vrater.
Get medical sttention if l-rritation develops or pe.rsints. If aigns of
ldtoxl_catlon (pol"sonj"ng) occur, B€t rnedlcal ettention tr-nunedlately.
INGESTI0Ni............ . l If lngestlon l-s suspected, cal-l a physician or poison control
center. If ntedlcsl asslstance cannot tre given i$nrediately, induce vomlEing and
get to a hospltal.
To lnduce vomitiilg, adrninJ-stet I or 2 glasses of water and etlck ftnger dor"m
throat. Repeat unti-l vomitus is clear. 0r, lf avalLable, admln{stet sytup of
lpecac (t/2 qz. or 15 rnl). Lf vorniting does not occur withirr 5-10 ninutes,
administer a second dose of lpecac.
Ilo not atEempt to giwe a.nythiug by
mrruch.
to fln unconscious or convulslng person.
INHALATI0N.............: If a par.son {s overcome by exeeesive expoeures to eero$o.ls or
vaporg of this tttaterial, Temove to fresh ait. sr uncontamlnated area. If not:
breathing, give artlflctsl resplr+tion., preferably mouth-to-rnquth. Get medlcel
attentlon &s soon as prrssible.
I'EYSICIAIT ..: AI{TIDOTE; Arlmlnlscer atropJ-rre sulfate ln J-arge theraperrtic
dt.r$€$. Repeat as necessary to the polnt of tolerance. Compound lnhlblts cholinesterase
reculc{ng in stimulatlon of the central nervous syetemr. the parasympathef,lc nervous
systeil) and the somatic noEor nerves. Do rrot gi.va norphlneg do rrot glve Z-P.AM, Watch
for pulmonary edema which ruey develop in serious caees of poisorring even after 12 hours.
At fitst nign of Pulmonary edema, the patlent should be placed ln sn sxygen tent afld
an.d creeced e5rmptomatica.lJ.y.
!{CITE TO
[-:i
J,'-1t-lij2[]18
ti.:li:
DS
iL4-tr.lT-l;t.1
I'..ITTFIICH CIEF -IALLAS
1
PAGE
E4
*.'.
}lSbS; NO BUGS },IIT,ADY SHEI,F
Pase 4
PAPER
VII:
EYE
PROTECTION. ....:
SKIN
PROTECTION..........
RESPIRATORY PROTECTION.
GoggLee
f\TTUTTD
should be ueed to prevent dust fron getting into
Ehe eyes-
:
., :
VENTILATlON.
EMPLOYEB ?ROTF,CTION RECOUMEtrDATIOilS
Avoid skln contact. Use eheml-cal-reglsEant gloves, boots,
Iong sleeves and long troueers to prevent dermal exPosure.
[Iear a respirator approved for pestlcldes by the Natlona]Institute for occupatl-onaL safety & Iiealth (NI0SH) .
Malntalil exposure leveIs below the exposure limit through
the use of general and Iocal exhauet ventllation.
Cleat water shouLd be aval1ab1e fot waah{-ng ln sase of eye
or skirr contantlnatlon. Educate arrd tral,n employeee ln eafe
use of the product. Follow al} tabel J"Ir$tfuctl-ons. Lsunder
cloth1-ng eeparately aft.et use, I,Iash choroughly after
handl.ing,
VIII.
REACTIVITY DATA
Stable
STABILITY
POLYMERTZATION.
CONDITIONS TO AVOTD... ..
INCO}TPA,TIBILITY
{:,{ATERIALS T0 A,VOTD).,,.
Vtrill not occnr.
Strstained temperstures above I00"F.
Alknltne materlals, strong oxldantq.
ILAZARDOt]S DECOMPOSITION
COr COr' CII3NCO, CH3NI{2
PRODUCTS
IX.
SPTLL OR LBAK
PROCEDT'RES
STSPS TO BE TAKEN IN CASE UAIBRIAL IS REIEASED OR SPIILI{DI Tsolate area ANd KEEP
ufl.cuthorl-eed people away- Do flot walk through sp{1-led materlal. Avotd breathtng dusts
and skl-n cont&.ct. l{ear praper prioteetive eqtripment. Carefully sweep up ab*orbed spilled
materl.a)". Pl.ace- Ln covered. cotrEatne-r for r:euse or: 4lsposaJ.. Scrub conEamlnated area
wJ"th detergenc and bJ.each soJ.rlElon. Repeet. Rlnee wlch nat.er. Contamlneted soll may have
to lre femoved and dfsposed. Do not allow naterial to enter streams, Eewers, or other
wa.terways or cofltact vegetatLon.
CIRCLA
RQ: No eomponents ll-sred.
corrts.lner label lnstructl-ons for disposal of wasf,ee
generatecl durlng use in compllance wlth the FIFRA product label.. Ln other eI-f,uatlons,
brtry tn s.fl EPA approved landfil,I or burn in an lncl-nerator epproved fon pesticide
I{.'\STE DI,$POSAL IffTtrODr Fol-lorrr
destruction.
RCRA
Do
not reuse container,
STAI{IS: Thie
material is not a haiardous waste under RCRA wtren disposed.
SSPERFIIIVD AI'jEND}{F;}IT AND REAUTEORIZATION
ACT (SARA), TITLE
III;
Sectlorr 302: Extrenel-y Hazar:dotrs Subsrancesl No componeflts Iiste6.
Sectl-on 313: Toxic Chemlcal"s: Propoxur (CAS /11L4-26-l) J.Z
U:i
,r
"J:r
!filU
'-t-:
i::
:1.1-E
:ll-2:i :li
I'...
I TTFI I
IH
I,JIFIP
FgrjE
-DALLAI:,
El_'
:'
MSI)S: NO BUGS M'LADY SHELF FAPER
fage
5
X.
STORAGE TBI"IPERATURE
S?ECI.AI PRE.CAUTIONS &
STOE.ACE DATA
(!rIN./!tAX.)-..; None/30 day average not to exceed
90oF'
S?ECI^AI SENSITIVITY (HEAT' I,IGIIT'
IIOISTURE)
PRECAUTIONS TO BE TAKfiN IN
ILc.NDI;ING AND ST0RING!.... '.
I l{eat ' mo*sture '
-.....: Store in a eqql dry area' Stote ln an area
desl-gnated specifically for pestlcldes' Do not store
neat any macerl-al" Lntended for use of consumptlon by
humans or animals.
0.0.T. Strtpplng Name...,, ' '. !
Te-chnical- Sh{ppJ.trg Name.... ':
D.O,T. Hazard Classiftcatlon':
;
UN/NAN0,...+...,
Reportable Quantlty..... ' +.. I
:
0,0.T. Labels Requlted.
......'i
D.O.T. Plaearde
;
Frt. Class Bulk.
:
Frt, CLs,ss PkS, -
Not
XI. SEIPPING DATA
RegulaLed
Propoxur
Not Appllcable
NotAppl"icable
Not Appllcable
Not Appllcable
Notre
Irrsectl-clde, 0/T Agriculturs,l' N'0'I.
Insecticl-de,, 0/T Agrlcultural, N.0.I.
XII.
ANIHAL TOXICI
T
: llala ret 2012 mg/kg;
1795 mslkg
FemaLe tat
rnl/kE
2000
(SKIN
Rabbltr
CONTACT).:
DERMAL, tD50
ORAL, nD50
(INGESTI0N)
INIIALATI.ON, I.CSO:
4 hour (Dust).,.,--..: Rat: 0.508 rng/L (nomlnal)
l, hour (Dust). . . ... . . : Rat: 20-0 mg/L (nominal)
(BxtrapolateJ frorn Baygon 70% Wettable Powder)
Rabbit; Mild eye Lrfltaflt.
EYE llFt'EcTS: . .
RABPTIT: Not a dermal lrritant.
SKIN EFFECTS:.
GuJ-nea pJ.g; Detmal eensltizatton atudles have flot
SENSITIZATION.
Pro'oxur
been
;::#i::t i: ::1.,';ffili'::li,li::;:''
terb studies have beerr performed on thl-s product a* fornulated. The follovirrg
inforruation perta1na Eo the active l-ngredf.ent'
No long
SU$CHROI{TC/cmoNlc TOXICITTT
Ir1 a two-week dermal toxlcl-ty scr-rdy on tabblcan B doso of 500nrg/kg/day ha-q no effect on
the general condltl-on, hody welgtrc gain, blood and utine, or llver and kldney functlon
of the animals,
grrvage study on Rhesus monkeys, d do.se of 40 ng/kglday resulted l-n
cirol"lnergic sympfoms lastln.g 5-I5 mirrutee after admlnietre.tlon; these J'ncluded
salivatlon, che\sj.ng, twitchhrg and rapid resplratl-on. A 502 deptesslon l-n pl-aema
chollrresterase occurred by one hour; thls retutfled to normaL by 24 houre after
In a 13 week oral
edml^nls
tratl-on.
;:l:l , ,'1:1,
;'!:1 1
!-'i
i t. Ft:l
!14-E
t7-!J:ri
f
:
ITTEIlH
CIIEP-LIALLAS
PA'JE
EE
;.
I'ISDS: NO BUGS MILADY SHELF
Page
PAPER
6
A one year study \das conducted wlth propoxur fed to dogs at doaea of 0, 200, 600 ancl
1.800 pprn (the hlgtr dose wss l-ncreased to 3600 pprn during th6 4lst week and then to
5400 ftom the 45th week untf-l the end of the study). Effeefe of treatment lncluded
elevated plasma choLesterol- levels arrd lrrcreaeed llver welght. Effecte at the hlgh dose
lncluded choll-nesterase irrhibition, teduced body welght gal-n ancl thymus atrophy.
fn a two year study, propoxur tr&s fed to rats 6t doses of 0,200, 1000 and 5000 pprn,
The NOEL was 200 ppm. Treatmenr with 5000 pprn resulted tn neuropathy, mugcular atrophy,
deeteased food coneulnDtLon and decreased bodv welght galn.
OTffBRT
CfIRCINOGENICITY.....: Propoxur rras fed td mice in the dlet
2000 and 6000 ppm for 24 months. Propoxur was not oncogenic
of this Etudy.
et dose 1eve1s of 0, J00,
in mlce under the condirious
Propoxttr Lnduced urltrary bladder carcinonas in. rats when fed at hlgh doses with slngle
type of dlet. Propoxur was not careinogen.ic when fed at htgh doses with alternate dlets.
These effects were not observed in experirnents on mIce, hamsters, doge or rnonkeys.
TERATOGENICIIT. : Propoxur rras fed to pregrrant rats ln thelr d{er doses of 0, 1000,
3000, and 10'000 ppm for the entire period of gescatlon. Ar doses of 3000 and 10,000
PFmr fhe mothers ate less and gained less wetght th.an controL anlmal-sl at these doses
the average fetnl welght was reduced. At the high doee, fetal developmeut r4ras nlowed,
No teratogenic effects were. ob.qerved.
Propoxur was fed by gavage to pregnant rsbblrs at doses of 0,1,3 and l0 rng/kg. There
no gdverse effects on emlrryonlc or fetal clevelopmerrt at doses up to iO mg/kg,
wa*re
RE#RODIICTL0N...... +. ! A, rat reproductlon study wlth the teehnical materl-al fed ln the
dtet was conducted at cgncentraclons of 250, 750, 2000 and, 6000 ppm. The reproducrlve
aad pdtental no-observed-effect-level was 750 ppm.
r4lrltActNlcrw. . . ,..,:
A wide varletv {f tn vi!q" aqd ln vlvo muragentcity studlee on
prokaryotic and eukaryotl-c systens indicate that propoxur is not mutagenl_c.
NEIIR0TOXICTTY- : No sfudles have been conducted on rhe fleuroto)riclty of propoxur
because lt is not an organophosphate chemf^ca_l..